Karl Engelman

5.1k total citations
69 papers, 3.8k citations indexed

About

Karl Engelman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Karl Engelman has authored 69 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 21 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Nutrition and Dietetics. Recurrent topics in Karl Engelman's work include Adrenal and Paraganglionic Tumors (19 papers), Pituitary Gland Disorders and Treatments (12 papers) and Biochemical Analysis and Sensing Techniques (9 papers). Karl Engelman is often cited by papers focused on Adrenal and Paraganglionic Tumors (19 papers), Pituitary Gland Disorders and Treatments (12 papers) and Biochemical Analysis and Sensing Techniques (9 papers). Karl Engelman collaborates with scholars based in United States, Malaysia and Italy. Karl Engelman's co-authors include Albert Sjoerdsma, Karen L. Teff, Barry Portnoy, Walter Lovenberg, Mary Bertino, Richard D. Mattes, Gary K. Beauchamp, David L. Horwitz, Nancy A. Hurley and Eric Jéquier and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Karl Engelman

67 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Engelman United States 37 881 843 806 550 490 69 3.8k
Eric Jéquier Switzerland 33 787 0.9× 869 1.0× 484 0.6× 1.1k 1.9× 756 1.5× 72 5.3k
David L. Horwitz United States 36 384 0.4× 2.2k 2.6× 1.5k 1.8× 1.1k 2.0× 216 0.4× 121 5.0k
Esmeralda Capristo Italy 42 600 0.7× 728 0.9× 1.1k 1.3× 610 1.1× 424 0.9× 133 4.7k
Michael L. Mathai Australia 36 757 0.9× 680 0.8× 482 0.6× 1.1k 1.9× 533 1.1× 147 4.5k
Mark I. Friedman United States 43 1.1k 1.2× 603 0.7× 635 0.8× 415 0.8× 1.9k 3.9× 134 5.1k
William J. Louis Australia 38 200 0.2× 465 0.6× 662 0.8× 1.1k 1.9× 378 0.8× 207 4.6k
Charlotte Erlanson‐Albertsson Sweden 36 1.0k 1.2× 880 1.0× 782 1.0× 1.0k 1.9× 1.4k 2.9× 153 4.5k
Robin E. Buckingham United Kingdom 33 512 0.6× 850 1.0× 505 0.6× 2.0k 3.6× 1.4k 2.9× 62 4.8k
Anthony L. McCall United States 35 345 0.4× 1.5k 1.8× 973 1.2× 1.0k 1.9× 479 1.0× 95 4.3k
Bilal Üstündağ Türkiye 40 470 0.5× 446 0.5× 337 0.4× 524 1.0× 481 1.0× 104 4.0k

Countries citing papers authored by Karl Engelman

Since Specialization
Citations

This map shows the geographic impact of Karl Engelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Engelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Engelman more than expected).

Fields of papers citing papers by Karl Engelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Engelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Engelman. The network helps show where Karl Engelman may publish in the future.

Co-authorship network of co-authors of Karl Engelman

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Engelman. A scholar is included among the top collaborators of Karl Engelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Engelman. Karl Engelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teff, Karen L. & Karl Engelman. (1996). Palatability and dietary restraint: Effect on cephalic phase insulin release in women. Physiology & Behavior. 60(2). 567–573. 65 indexed citations
2.
Teff, Karen L. & Karl Engelman. (1996). Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 270(6). R1371–R1379. 107 indexed citations
3.
Mattes, Richard D., et al.. (1994). Cannabinoids and appetite stimulation. Pharmacology Biochemistry and Behavior. 49(1). 187–195. 131 indexed citations
4.
Mattes, Richard D., Yi‐Ju Li, & Karl Engelman. (1994). Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. Chemical Senses. 19(2). 125–140. 26 indexed citations
5.
Mattes, Richard D., et al.. (1993). Bypassing the first-pass effect for the therapeutic use of cannabinoids. Pharmacology Biochemistry and Behavior. 44(3). 745–747. 47 indexed citations
6.
Teff, Karen L., Richard D. Mattes, Karl Engelman, & J Mattern. (1993). Cephalic-phase insulin in obese and normal-weight men: Relation to postprandial insulin. Metabolism. 42(12). 1600–1608. 57 indexed citations
7.
Mattes, Richard D. & Karl Engelman. (1992). Effects of combined hydrochlorothiazide and amiloride versus single drug on changes in salt taste and intake. The American Journal of Cardiology. 70(1). 91–95. 5 indexed citations
8.
Mattes, Richard D., Carol M. Christensen, & Karl Engelman. (1990). Effects of Hydrochlorothiazide and Amiloride on Salt Taste and Excretion (Intake). American Journal of Hypertension. 3(6 Pt 1). 436–443. 12 indexed citations
9.
Bertino, Mary, et al.. (1990). Experimental sodium depletion and salt taste in normal human volunteers. American Journal of Clinical Nutrition. 51(5). 881–889. 106 indexed citations
10.
Engelman, Karl. (1988). Side effects of sympatholytic antihypertensive drugs.. Hypertension. 11(3_pt_2). II30–3. 7 indexed citations
11.
Christensen, Carol M., Mary Bertino, Gary K. Beauchamp, M. Navazesh, & Karl Engelman. (1986). The influence of moderate reduction in dietary sodium on human salivary sodium concentration. Archives of Oral Biology. 31(12). 825–828. 3 indexed citations
12.
Engelman, Karl. (1977). Phaeochromocytoma. Clinics in Endocrinology and Metabolism. 6(3). 769–797. 47 indexed citations
13.
Reichgott, Michael J. & Karl Engelman. (1975). Indomethacin: lack of effect on lethality of endotoxin in rats. 2(3). 215–219. 6 indexed citations
14.
Wolfson, Steven, et al.. (1972). Effects of conditioning on plasma catecholamine levels during exercise in patients with coronary artery disease. The American Journal of Cardiology. 29(2). 297–298. 5 indexed citations
15.
Wyatt, Richard Jed, Vincent P. Zarcone, Karl Engelman, et al.. (1971). Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalography and Clinical Neurophysiology. 30(6). 505–509. 49 indexed citations
16.
Engelman, Karl, Barry Portnoy, & Nancy A. Hurley. (1970). A Sensitive Double-Isotope Derivative Assay for Norepinephrine and Epinephrine. Circulation Research. 26(1). 53–57. 209 indexed citations
17.
Cooperman, Lee H., et al.. (1967). Anesthetic Management of Pheochromocytoma Employing Halothane and Beta Adrenergic Blockade . Anesthesiology. 28(3). 575–582. 24 indexed citations
18.
Engelman, Karl, et al.. (1964). Chronic Medical Therapy for Pheochromocytoma. Annals of Internal Medicine. 61(2). 229–241. 68 indexed citations
19.
Studnitz, Wilfried von, Karl Engelman, & Albert Sjoerdsma. (1964). Urinary excretion of phenolic acids in human subjects on a glucose diet. Clinica Chimica Acta. 9(3). 224–227. 22 indexed citations
20.
Rosenstein, Beryl J. & Karl Engelman. (1963). Diarrhea in a child with a catecholamine-secreting ganglioneuroma. The Journal of Pediatrics. 63(2). 217–226. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Jéquier Breakdown of academic impact, for papers by David L. Horwitz Breakdown of academic impact, for papers by Esmeralda Capristo Breakdown of academic impact, for papers by Michael L. Mathai Breakdown of academic impact, for papers by Mark I. Friedman Breakdown of academic impact, for papers by William J. Louis Breakdown of academic impact, for papers by Charlotte Erlanson‐Albertsson Breakdown of academic impact, for papers by Robin E. Buckingham Breakdown of academic impact, for papers by Anthony L. McCall Breakdown of academic impact, for papers by Bilal Üstündağ
Rankless by CCL
2026